The Role of NF-κB in Diabetic Heart Disease
Author Information
Author(s): Lorenzo O. Lorenzo, Picatoste B., Ares-Carrasco S., Ramírez E., Egido J., Tuñón J.
Primary Institution: Instituto de Investigaciones Sanitarias IIS-Fundación Jiménez Díaz
Hypothesis
What is the role of nuclear factor kappa B (NF-κB) in diabetic cardiomyopathy?
Conclusion
NF-κB plays a critical role in the mechanisms of diabetic cardiomyopathy, influencing processes like oxidative stress, inflammation, and fibrosis.
Supporting Evidence
- Diabetic patients are at increased risk of heart failure, which is a major cause of death.
- NF-κB is activated by various stimuli, including high glucose levels and inflammatory cytokines.
- Oxidative stress and inflammation are key processes regulated by NF-κB in diabetic cardiomyopathy.
Takeaway
Diabetes can hurt the heart, and a protein called NF-κB helps control how this happens. Understanding NF-κB might help us find better treatments for heart problems in people with diabetes.
Methodology
This review discusses the NF-κB signaling pathways and their implications in diabetic cardiomyopathy based on existing literature and studies.
Limitations
The review primarily relies on animal models and existing literature, which may not fully represent human conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website